MedTrace Logo

Rapid POC GAS Diagnostics in the Paediatric ED

NCT04247243 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 392

Last updated 2024-10-03

No results posted yet for this study

Summary

Randomized trial evaluating effectiveness of rapid point-of-care molecular GAS diagnostics as compared to standard culture-based techniques for the management of children aged 3-18 years of age presenting with sore throat to McMaster Children's Hospital Emergency Department.

Conditions

  • Streptococcal Pharyngitis

Interventions

DEVICE

Rapid testing

Abbott ID NOW Strep A testing

DIAGNOSTIC_TEST

Reference testing

Culture-based testing

Sponsors & Collaborators

  • Hamilton Health Sciences Corporation

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-04
Primary Completion
2024-03-25
Completion
2024-04-04
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04247243 on ClinicalTrials.gov